Home Biosimilar Antibodies Immunology & Inflammation CD markers antibody Drozitumab (Anti-TNFRSF10B / TRAILR2 / CD262) For research use only.
Not for use in humans.

Drozitumab (Anti-TNFRSF10B / TRAILR2 / CD262)

Synonyms: PRO 95780

Drozitumab (Anti-TNFRSF10B / TRAILR2 / CD262) is a human monoclonal antibody targeted against the death receptor DR5 (TRAILR2, CD262, TNFRSF10B) with potent anti-tumor activity against rhabdomyosarcoma (RMS) xenografts. MW: 150 kD.

Drozitumab (Anti-TNFRSF10B / TRAILR2 / CD262)

Purity & Quality Control

≥99

Choose Selective CD markers Inhibitors

Biological Activity

Description Drozitumab (Anti-TNFRSF10B / TRAILR2 / CD262) is a human monoclonal antibody targeted against the death receptor DR5 (TRAILR2, CD262, TNFRSF10B) with potent anti-tumor activity against rhabdomyosarcoma (RMS) xenografts. MW: 150 kD.

Product Details

CAS No. 912628-39-8
Molecular Weight 150
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Drozitumab (Anti-TNFRSF10B / TRAILR2 / CD262) | Drozitumab (Anti-TNFRSF10B / TRAILR2 / CD262) supplier | purchase Drozitumab (Anti-TNFRSF10B / TRAILR2 / CD262) | Drozitumab (Anti-TNFRSF10B / TRAILR2 / CD262) cost | Drozitumab (Anti-TNFRSF10B / TRAILR2 / CD262) manufacturer | order Drozitumab (Anti-TNFRSF10B / TRAILR2 / CD262) | Drozitumab (Anti-TNFRSF10B / TRAILR2 / CD262) distributor